nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorhexidine—SLC22A3—Vincristine—kidney cancer	0.248	0.624	CbGbCtD
Chlorhexidine—SLC22A2—Vinblastine—kidney cancer	0.149	0.376	CbGbCtD
Chlorhexidine—SLC22A2—nephron—kidney cancer	0.0298	0.182	CbGeAlD
Chlorhexidine—SLC47A2—renal system—kidney cancer	0.0141	0.0865	CbGeAlD
Chlorhexidine—SLC47A2—kidney—kidney cancer	0.0137	0.0836	CbGeAlD
Chlorhexidine—SLC47A2—cortex of kidney—kidney cancer	0.0133	0.0814	CbGeAlD
Chlorhexidine—HNMT—nephron tubule—kidney cancer	0.00911	0.0558	CbGeAlD
Chlorhexidine—HNMT—renal system—kidney cancer	0.00828	0.0507	CbGeAlD
Chlorhexidine—HNMT—kidney—kidney cancer	0.00801	0.049	CbGeAlD
Chlorhexidine—SLC22A2—nephron tubule—kidney cancer	0.00643	0.0393	CbGeAlD
Chlorhexidine—SLC22A2—renal system—kidney cancer	0.00584	0.0358	CbGeAlD
Chlorhexidine—SLC22A2—kidney—kidney cancer	0.00565	0.0346	CbGeAlD
Chlorhexidine—SLC22A2—cortex of kidney—kidney cancer	0.0055	0.0337	CbGeAlD
Chlorhexidine—SLC47A1—nephron tubule—kidney cancer	0.00544	0.0333	CbGeAlD
Chlorhexidine—SLC47A1—renal system—kidney cancer	0.00495	0.0303	CbGeAlD
Chlorhexidine—SLC47A1—kidney—kidney cancer	0.00478	0.0293	CbGeAlD
Chlorhexidine—SLC47A1—cortex of kidney—kidney cancer	0.00466	0.0285	CbGeAlD
Chlorhexidine—SLC47A1—gonad—kidney cancer	0.00443	0.0271	CbGeAlD
Chlorhexidine—SLC22A1—renal system—kidney cancer	0.00413	0.0253	CbGeAlD
Chlorhexidine—SLC22A1—kidney—kidney cancer	0.00399	0.0244	CbGeAlD
Chlorhexidine—SLC22A3—renal system—kidney cancer	0.00394	0.0241	CbGeAlD
Chlorhexidine—SLC22A3—kidney—kidney cancer	0.00381	0.0233	CbGeAlD
Chlorhexidine—SLC22A3—gonad—kidney cancer	0.00354	0.0217	CbGeAlD
Chlorhexidine—SLC22A3—Abacavir transmembrane transport—ABCB1—kidney cancer	0.00294	0.0701	CbGpPWpGaD
Chlorhexidine—Influenza like illness—Sorafenib—kidney cancer	0.0024	0.00604	CcSEcCtD
Chlorhexidine—Ulcer—Dactinomycin—kidney cancer	0.00238	0.00599	CcSEcCtD
Chlorhexidine—Redness—Paclitaxel—kidney cancer	0.00236	0.00595	CcSEcCtD
Chlorhexidine—Skin exfoliation—Sorafenib—kidney cancer	0.00236	0.00594	CcSEcCtD
Chlorhexidine—Influenza like illness—Sunitinib—kidney cancer	0.00231	0.00581	CcSEcCtD
Chlorhexidine—Bronchitis—Temsirolimus—kidney cancer	0.00231	0.00581	CcSEcCtD
Chlorhexidine—Skin exfoliation—Sunitinib—kidney cancer	0.00227	0.00571	CcSEcCtD
Chlorhexidine—Influenza-like symptoms—Paclitaxel—kidney cancer	0.00223	0.00563	CcSEcCtD
Chlorhexidine—Mouth ulceration—Sorafenib—kidney cancer	0.00223	0.00562	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Temsirolimus—kidney cancer	0.00223	0.00561	CcSEcCtD
Chlorhexidine—Tenderness—Gemcitabine—kidney cancer	0.00219	0.0055	CcSEcCtD
Chlorhexidine—Mouth ulceration—Sunitinib—kidney cancer	0.00215	0.00541	CcSEcCtD
Chlorhexidine—Stomatitis—Temsirolimus—kidney cancer	0.00209	0.00525	CcSEcCtD
Chlorhexidine—Mouth ulceration—Dactinomycin—kidney cancer	0.00203	0.00512	CcSEcCtD
Chlorhexidine—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00203	0.0482	CbGpPWpGaD
Chlorhexidine—Ulcer—Gemcitabine—kidney cancer	0.00202	0.00507	CcSEcCtD
Chlorhexidine—Sinusitis—Temsirolimus—kidney cancer	0.00201	0.00505	CcSEcCtD
Chlorhexidine—Stomatitis—Pazopanib—kidney cancer	0.00196	0.00495	CcSEcCtD
Chlorhexidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.00193	0.046	CbGpPWpGaD
Chlorhexidine—Rhinitis—Temsirolimus—kidney cancer	0.00193	0.00485	CcSEcCtD
Chlorhexidine—Pharyngitis—Temsirolimus—kidney cancer	0.00191	0.0048	CcSEcCtD
Chlorhexidine—Influenza like illness—Gemcitabine—kidney cancer	0.00185	0.00466	CcSEcCtD
Chlorhexidine—SLC22A2—Abacavir transmembrane transport—ABCB1—kidney cancer	0.00185	0.0439	CbGpPWpGaD
Chlorhexidine—Tenderness—Paclitaxel—kidney cancer	0.00183	0.00461	CcSEcCtD
Chlorhexidine—Ulcerative stomatitis—Doxorubicin—kidney cancer	0.00183	0.0046	CcSEcCtD
Chlorhexidine—Skin exfoliation—Gemcitabine—kidney cancer	0.00182	0.00458	CcSEcCtD
Chlorhexidine—Mouth ulceration—Vincristine—kidney cancer	0.00182	0.00457	CcSEcCtD
Chlorhexidine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.0018	0.0429	CbGpPWpGaD
Chlorhexidine—Tongue disorder—Capecitabine—kidney cancer	0.0018	0.00453	CcSEcCtD
Chlorhexidine—Aphthous stomatitis—Doxorubicin—kidney cancer	0.0018	0.00453	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Pazopanib—kidney cancer	0.0018	0.00453	CcSEcCtD
Chlorhexidine—SLC22A1—Abacavir transmembrane transport—ABCB1—kidney cancer	0.00172	0.041	CbGpPWpGaD
Chlorhexidine—Bronchitis—Everolimus—kidney cancer	0.00172	0.00432	CcSEcCtD
Chlorhexidine—SLC22A3—Abacavir transport and metabolism—ABCB1—kidney cancer	0.00169	0.0402	CbGpPWpGaD
Chlorhexidine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.00168	0.0401	CbGpPWpGaD
Chlorhexidine—Erythema—Temsirolimus—kidney cancer	0.00167	0.00421	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Everolimus—kidney cancer	0.00166	0.00418	CcSEcCtD
Chlorhexidine—Dysgeusia—Temsirolimus—kidney cancer	0.00164	0.00412	CcSEcCtD
Chlorhexidine—Back pain—Temsirolimus—kidney cancer	0.00162	0.00407	CcSEcCtD
Chlorhexidine—Erythema—Pazopanib—kidney cancer	0.00157	0.00397	CcSEcCtD
Chlorhexidine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.00157	0.0373	CbGpPWpGaD
Chlorhexidine—Stomatitis—Everolimus—kidney cancer	0.00155	0.00391	CcSEcCtD
Chlorhexidine—Influenza like illness—Paclitaxel—kidney cancer	0.00155	0.0039	CcSEcCtD
Chlorhexidine—Dysgeusia—Pazopanib—kidney cancer	0.00154	0.00388	CcSEcCtD
Chlorhexidine—Skin exfoliation—Paclitaxel—kidney cancer	0.00152	0.00384	CcSEcCtD
Chlorhexidine—Stomatitis—Erlotinib—kidney cancer	0.0015	0.00377	CcSEcCtD
Chlorhexidine—Sinusitis—Everolimus—kidney cancer	0.00149	0.00376	CcSEcCtD
Chlorhexidine—Gingival bleeding—Doxorubicin—kidney cancer	0.00149	0.00375	CcSEcCtD
Chlorhexidine—Cough—Temsirolimus—kidney cancer	0.00146	0.00367	CcSEcCtD
Chlorhexidine—Hypertension—Temsirolimus—kidney cancer	0.00144	0.00363	CcSEcCtD
Chlorhexidine—Mouth ulceration—Paclitaxel—kidney cancer	0.00144	0.00363	CcSEcCtD
Chlorhexidine—Bronchitis—Sunitinib—kidney cancer	0.00143	0.00361	CcSEcCtD
Chlorhexidine—Rhinitis—Everolimus—kidney cancer	0.00143	0.00361	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Vinblastine—kidney cancer	0.00143	0.00359	CcSEcCtD
Chlorhexidine—Pharyngitis—Vinblastine—kidney cancer	0.00142	0.00358	CcSEcCtD
Chlorhexidine—Arthralgia—Temsirolimus—kidney cancer	0.00142	0.00358	CcSEcCtD
Chlorhexidine—Myalgia—Temsirolimus—kidney cancer	0.00142	0.00358	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Everolimus—kidney cancer	0.00142	0.00358	CcSEcCtD
Chlorhexidine—Pharyngitis—Everolimus—kidney cancer	0.00142	0.00357	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Sunitinib—kidney cancer	0.00139	0.00349	CcSEcCtD
Chlorhexidine—Ulcer—Capecitabine—kidney cancer	0.00138	0.00349	CcSEcCtD
Chlorhexidine—Cough—Pazopanib—kidney cancer	0.00137	0.00346	CcSEcCtD
Chlorhexidine—Anaphylactic shock—Temsirolimus—kidney cancer	0.00136	0.00344	CcSEcCtD
Chlorhexidine—Hypertension—Pazopanib—kidney cancer	0.00136	0.00342	CcSEcCtD
Chlorhexidine—Stomatitis—Sorafenib—kidney cancer	0.00135	0.00339	CcSEcCtD
Chlorhexidine—Arthralgia—Pazopanib—kidney cancer	0.00134	0.00338	CcSEcCtD
Chlorhexidine—Myalgia—Pazopanib—kidney cancer	0.00134	0.00338	CcSEcCtD
Chlorhexidine—Swelling—Paclitaxel—kidney cancer	0.00131	0.00331	CcSEcCtD
Chlorhexidine—Dry mouth—Pazopanib—kidney cancer	0.00131	0.0033	CcSEcCtD
Chlorhexidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00131	0.0311	CbGpPWpGaD
Chlorhexidine—Stomatitis—Sunitinib—kidney cancer	0.0013	0.00326	CcSEcCtD
Chlorhexidine—Influenza like illness—Capecitabine—kidney cancer	0.00127	0.0032	CcSEcCtD
Chlorhexidine—Injury—Paclitaxel—kidney cancer	0.00126	0.00317	CcSEcCtD
Chlorhexidine—Redness—Doxorubicin—kidney cancer	0.00125	0.00315	CcSEcCtD
Chlorhexidine—Skin exfoliation—Capecitabine—kidney cancer	0.00125	0.00315	CcSEcCtD
Chlorhexidine—Erythema—Everolimus—kidney cancer	0.00124	0.00313	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.00124	0.00313	CcSEcCtD
Chlorhexidine—Stomatitis—Dactinomycin—kidney cancer	0.00123	0.00309	CcSEcCtD
Chlorhexidine—Dysgeusia—Everolimus—kidney cancer	0.00122	0.00307	CcSEcCtD
Chlorhexidine—Burning sensation—Doxorubicin—kidney cancer	0.00122	0.00306	CcSEcCtD
Chlorhexidine—Back pain—Everolimus—kidney cancer	0.0012	0.00303	CcSEcCtD
Chlorhexidine—Erythema—Erlotinib—kidney cancer	0.0012	0.00302	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Sunitinib—kidney cancer	0.00119	0.00299	CcSEcCtD
Chlorhexidine—Mouth ulceration—Capecitabine—kidney cancer	0.00118	0.00298	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00117	0.00295	CcSEcCtD
Chlorhexidine—Pain—Temsirolimus—kidney cancer	0.00117	0.00294	CcSEcCtD
Chlorhexidine—Back pain—Erlotinib—kidney cancer	0.00116	0.00292	CcSEcCtD
Chlorhexidine—Paraesthesia—Pazopanib—kidney cancer	0.00115	0.00291	CcSEcCtD
Chlorhexidine—Dyspepsia—Pazopanib—kidney cancer	0.00113	0.00285	CcSEcCtD
Chlorhexidine—Pharyngitis—Dactinomycin—kidney cancer	0.00112	0.00282	CcSEcCtD
Chlorhexidine—Pain—Pazopanib—kidney cancer	0.0011	0.00277	CcSEcCtD
Chlorhexidine—Stomatitis—Vincristine—kidney cancer	0.0011	0.00276	CcSEcCtD
Chlorhexidine—Cough—Everolimus—kidney cancer	0.00109	0.00273	CcSEcCtD
Chlorhexidine—Erythema—Sorafenib—kidney cancer	0.00108	0.00272	CcSEcCtD
Chlorhexidine—Swelling—Capecitabine—kidney cancer	0.00108	0.00271	CcSEcCtD
Chlorhexidine—Hypertension—Vinblastine—kidney cancer	0.00108	0.00271	CcSEcCtD
Chlorhexidine—Hypertension—Everolimus—kidney cancer	0.00107	0.0027	CcSEcCtD
Chlorhexidine—Abscess—Doxorubicin—kidney cancer	0.00107	0.00269	CcSEcCtD
Chlorhexidine—SLC22A2—Abacavir transport and metabolism—ABCB1—kidney cancer	0.00106	0.0252	CbGpPWpGaD
Chlorhexidine—Arthralgia—Everolimus—kidney cancer	0.00106	0.00267	CcSEcCtD
Chlorhexidine—Myalgia—Everolimus—kidney cancer	0.00106	0.00267	CcSEcCtD
Chlorhexidine—Dysgeusia—Sorafenib—kidney cancer	0.00106	0.00266	CcSEcCtD
Chlorhexidine—Discomfort—Vinblastine—kidney cancer	0.00105	0.00264	CcSEcCtD
Chlorhexidine—Cough—Erlotinib—kidney cancer	0.00105	0.00264	CcSEcCtD
Chlorhexidine—Discomfort—Everolimus—kidney cancer	0.00105	0.00263	CcSEcCtD
Chlorhexidine—Stomatitis—Gemcitabine—kidney cancer	0.00104	0.00262	CcSEcCtD
Chlorhexidine—Erythema—Sunitinib—kidney cancer	0.00104	0.00262	CcSEcCtD
Chlorhexidine—Dry mouth—Everolimus—kidney cancer	0.00104	0.00261	CcSEcCtD
Chlorhexidine—Arthralgia—Erlotinib—kidney cancer	0.00102	0.00257	CcSEcCtD
Chlorhexidine—Myalgia—Erlotinib—kidney cancer	0.00102	0.00257	CcSEcCtD
Chlorhexidine—Dysgeusia—Sunitinib—kidney cancer	0.00102	0.00256	CcSEcCtD
Chlorhexidine—Hypersensitivity—Temsirolimus—kidney cancer	0.00101	0.00253	CcSEcCtD
Chlorhexidine—Back pain—Sunitinib—kidney cancer	0.001	0.00253	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Vincristine—kidney cancer	0.001	0.00253	CcSEcCtD
Chlorhexidine—SLC22A1—Abacavir transport and metabolism—ABCB1—kidney cancer	0.000989	0.0235	CbGpPWpGaD
Chlorhexidine—Erythema—Dactinomycin—kidney cancer	0.000983	0.00248	CcSEcCtD
Chlorhexidine—Bronchitis—Paclitaxel—kidney cancer	0.000963	0.00242	CcSEcCtD
Chlorhexidine—Rhinitis—Gemcitabine—kidney cancer	0.00096	0.00242	CcSEcCtD
Chlorhexidine—Osteoarthritis—Capecitabine—kidney cancer	0.000951	0.00239	CcSEcCtD
Chlorhexidine—Pharyngitis—Gemcitabine—kidney cancer	0.00095	0.00239	CcSEcCtD
Chlorhexidine—Cough—Sorafenib—kidney cancer	0.000942	0.00237	CcSEcCtD
Chlorhexidine—Hypertension—Sorafenib—kidney cancer	0.000932	0.00235	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000931	0.00234	CcSEcCtD
Chlorhexidine—Arthropathy—Doxorubicin—kidney cancer	0.000929	0.00234	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000925	0.00233	CcSEcCtD
Chlorhexidine—SLC47A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000921	0.0219	CbGpPWpGaD
Chlorhexidine—Myalgia—Sorafenib—kidney cancer	0.000919	0.00231	CcSEcCtD
Chlorhexidine—Arthralgia—Sorafenib—kidney cancer	0.000919	0.00231	CcSEcCtD
Chlorhexidine—Glossitis—Doxorubicin—kidney cancer	0.000916	0.00231	CcSEcCtD
Chlorhexidine—Paraesthesia—Vinblastine—kidney cancer	0.000915	0.0023	CcSEcCtD
Chlorhexidine—Paraesthesia—Everolimus—kidney cancer	0.000911	0.00229	CcSEcCtD
Chlorhexidine—Cough—Sunitinib—kidney cancer	0.000906	0.00228	CcSEcCtD
Chlorhexidine—Dry mouth—Sorafenib—kidney cancer	0.000899	0.00226	CcSEcCtD
Chlorhexidine—Hypertension—Sunitinib—kidney cancer	0.000897	0.00226	CcSEcCtD
Chlorhexidine—Dyspepsia—Everolimus—kidney cancer	0.000893	0.00225	CcSEcCtD
Chlorhexidine—Ulcer—Doxorubicin—kidney cancer	0.000893	0.00225	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000892	0.00225	CcSEcCtD
Chlorhexidine—Arthralgia—Sunitinib—kidney cancer	0.000884	0.00223	CcSEcCtD
Chlorhexidine—Myalgia—Sunitinib—kidney cancer	0.000884	0.00223	CcSEcCtD
Chlorhexidine—Anaphylactic shock—Sorafenib—kidney cancer	0.000881	0.00222	CcSEcCtD
Chlorhexidine—Pain—Vinblastine—kidney cancer	0.000871	0.00219	CcSEcCtD
Chlorhexidine—Stomatitis—Paclitaxel—kidney cancer	0.00087	0.00219	CcSEcCtD
Chlorhexidine—Pain—Everolimus—kidney cancer	0.000868	0.00219	CcSEcCtD
Chlorhexidine—Dry mouth—Sunitinib—kidney cancer	0.000865	0.00218	CcSEcCtD
Chlorhexidine—Dyspepsia—Erlotinib—kidney cancer	0.000862	0.00217	CcSEcCtD
Chlorhexidine—Headache—Temsirolimus—kidney cancer	0.000855	0.00215	CcSEcCtD
Chlorhexidine—Back pain—Vincristine—kidney cancer	0.00085	0.00214	CcSEcCtD
Chlorhexidine—Sinusitis—Paclitaxel—kidney cancer	0.000838	0.00211	CcSEcCtD
Chlorhexidine—Pain—Erlotinib—kidney cancer	0.000837	0.00211	CcSEcCtD
Chlorhexidine—Myalgia—Dactinomycin—kidney cancer	0.000837	0.00211	CcSEcCtD
Chlorhexidine—Erythema—Gemcitabine—kidney cancer	0.000833	0.0021	CcSEcCtD
Chlorhexidine—Discomfort—Dactinomycin—kidney cancer	0.000827	0.00208	CcSEcCtD
Chlorhexidine—Influenza like illness—Doxorubicin—kidney cancer	0.00082	0.00206	CcSEcCtD
Chlorhexidine—SLC47A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000815	0.0194	CbGpPWpGaD
Chlorhexidine—Back pain—Gemcitabine—kidney cancer	0.000806	0.00203	CcSEcCtD
Chlorhexidine—Skin exfoliation—Doxorubicin—kidney cancer	0.000806	0.00203	CcSEcCtD
Chlorhexidine—Headache—Pazopanib—kidney cancer	0.000805	0.00203	CcSEcCtD
Chlorhexidine—Rhinitis—Paclitaxel—kidney cancer	0.000804	0.00202	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000803	0.00202	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Paclitaxel—kidney cancer	0.000798	0.00201	CcSEcCtD
Chlorhexidine—Pharyngitis—Paclitaxel—kidney cancer	0.000796	0.002	CcSEcCtD
Chlorhexidine—Bronchitis—Capecitabine—kidney cancer	0.00079	0.00199	CcSEcCtD
Chlorhexidine—Dyspepsia—Sorafenib—kidney cancer	0.000775	0.00195	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000772	0.00194	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000764	0.00192	CcSEcCtD
Chlorhexidine—Mouth ulceration—Doxorubicin—kidney cancer	0.000763	0.00192	CcSEcCtD
Chlorhexidine—Paraesthesia—Sunitinib—kidney cancer	0.000761	0.00192	CcSEcCtD
Chlorhexidine—Hypertension—Vincristine—kidney cancer	0.000758	0.00191	CcSEcCtD
Chlorhexidine—Pain—Sorafenib—kidney cancer	0.000753	0.0019	CcSEcCtD
Chlorhexidine—Hypersensitivity—Vinblastine—kidney cancer	0.000751	0.00189	CcSEcCtD
Chlorhexidine—Myalgia—Vincristine—kidney cancer	0.000748	0.00188	CcSEcCtD
Chlorhexidine—Hypersensitivity—Everolimus—kidney cancer	0.000748	0.00188	CcSEcCtD
Chlorhexidine—Dyspepsia—Sunitinib—kidney cancer	0.000746	0.00188	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000731	0.00184	CcSEcCtD
Chlorhexidine—Cough—Gemcitabine—kidney cancer	0.000727	0.00183	CcSEcCtD
Chlorhexidine—Pain—Sunitinib—kidney cancer	0.000725	0.00183	CcSEcCtD
Chlorhexidine—Hypertension—Gemcitabine—kidney cancer	0.00072	0.00181	CcSEcCtD
Chlorhexidine—Anaphylactic shock—Vincristine—kidney cancer	0.000717	0.00181	CcSEcCtD
Chlorhexidine—Stomatitis—Capecitabine—kidney cancer	0.000714	0.0018	CcSEcCtD
Chlorhexidine—Myalgia—Gemcitabine—kidney cancer	0.00071	0.00179	CcSEcCtD
Chlorhexidine—Arthralgia—Gemcitabine—kidney cancer	0.00071	0.00179	CcSEcCtD
Chlorhexidine—HNMT—Metapathway biotransformation—GSTP1—kidney cancer	0.000709	0.0169	CbGpPWpGaD
Chlorhexidine—Discomfort—Gemcitabine—kidney cancer	0.000701	0.00176	CcSEcCtD
Chlorhexidine—Urticaria—Sorafenib—kidney cancer	0.0007	0.00176	CcSEcCtD
Chlorhexidine—Erythema—Paclitaxel—kidney cancer	0.000698	0.00176	CcSEcCtD
Chlorhexidine—Pain—Dactinomycin—kidney cancer	0.000686	0.00173	CcSEcCtD
Chlorhexidine—Dysgeusia—Paclitaxel—kidney cancer	0.000683	0.00172	CcSEcCtD
Chlorhexidine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000683	0.0163	CbGpPWpGaD
Chlorhexidine—Anaphylactic shock—Gemcitabine—kidney cancer	0.00068	0.00171	CcSEcCtD
Chlorhexidine—Back pain—Paclitaxel—kidney cancer	0.000675	0.0017	CcSEcCtD
Chlorhexidine—Rhinitis—Capecitabine—kidney cancer	0.000659	0.00166	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Capecitabine—kidney cancer	0.000654	0.00165	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000653	0.00164	CcSEcCtD
Chlorhexidine—Pharyngitis—Capecitabine—kidney cancer	0.000653	0.00164	CcSEcCtD
Chlorhexidine—HNMT—Metapathway biotransformation—GSTM1—kidney cancer	0.000651	0.0155	CbGpPWpGaD
Chlorhexidine—Hypersensitivity—Sorafenib—kidney cancer	0.000649	0.00163	CcSEcCtD
Chlorhexidine—Paraesthesia—Vincristine—kidney cancer	0.000644	0.00162	CcSEcCtD
Chlorhexidine—Headache—Vinblastine—kidney cancer	0.000638	0.00161	CcSEcCtD
Chlorhexidine—Headache—Everolimus—kidney cancer	0.000636	0.0016	CcSEcCtD
Chlorhexidine—Hypersensitivity—Sunitinib—kidney cancer	0.000625	0.00157	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00062	0.00156	CcSEcCtD
Chlorhexidine—HNMT—Metapathway biotransformation—CYP1A1—kidney cancer	0.000618	0.0147	CbGpPWpGaD
Chlorhexidine—Headache—Erlotinib—kidney cancer	0.000613	0.00154	CcSEcCtD
Chlorhexidine—Pain—Vincristine—kidney cancer	0.000613	0.00154	CcSEcCtD
Chlorhexidine—Osteoarthritis—Doxorubicin—kidney cancer	0.000613	0.00154	CcSEcCtD
Chlorhexidine—Paraesthesia—Gemcitabine—kidney cancer	0.000611	0.00154	CcSEcCtD
Chlorhexidine—Cough—Paclitaxel—kidney cancer	0.000609	0.00153	CcSEcCtD
Chlorhexidine—Hypertension—Paclitaxel—kidney cancer	0.000602	0.00152	CcSEcCtD
Chlorhexidine—Arthralgia—Paclitaxel—kidney cancer	0.000594	0.0015	CcSEcCtD
Chlorhexidine—Myalgia—Paclitaxel—kidney cancer	0.000594	0.0015	CcSEcCtD
Chlorhexidine—SLC47A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000594	0.0141	CbGpPWpGaD
Chlorhexidine—Hypersensitivity—Dactinomycin—kidney cancer	0.000591	0.00149	CcSEcCtD
Chlorhexidine—Discomfort—Paclitaxel—kidney cancer	0.000587	0.00148	CcSEcCtD
Chlorhexidine—Pain—Gemcitabine—kidney cancer	0.000582	0.00146	CcSEcCtD
Chlorhexidine—Dry mouth—Paclitaxel—kidney cancer	0.000581	0.00146	CcSEcCtD
Chlorhexidine—Erythema—Capecitabine—kidney cancer	0.000573	0.00144	CcSEcCtD
Chlorhexidine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000569	0.00143	CcSEcCtD
Chlorhexidine—Dysgeusia—Capecitabine—kidney cancer	0.000561	0.00141	CcSEcCtD
Chlorhexidine—Back pain—Capecitabine—kidney cancer	0.000554	0.00139	CcSEcCtD
Chlorhexidine—Headache—Sorafenib—kidney cancer	0.000552	0.00139	CcSEcCtD
Chlorhexidine—Headache—Sunitinib—kidney cancer	0.000531	0.00134	CcSEcCtD
Chlorhexidine—Hypersensitivity—Vincristine—kidney cancer	0.000528	0.00133	CcSEcCtD
Chlorhexidine—SLC47A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000525	0.0125	CbGpPWpGaD
Chlorhexidine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000519	0.00131	CcSEcCtD
Chlorhexidine—Paraesthesia—Paclitaxel—kidney cancer	0.000511	0.00129	CcSEcCtD
Chlorhexidine—Bronchitis—Doxorubicin—kidney cancer	0.000509	0.00128	CcSEcCtD
Chlorhexidine—Dyspepsia—Paclitaxel—kidney cancer	0.000501	0.00126	CcSEcCtD
Chlorhexidine—Cough—Capecitabine—kidney cancer	0.0005	0.00126	CcSEcCtD
Chlorhexidine—Hypertension—Capecitabine—kidney cancer	0.000494	0.00124	CcSEcCtD
Chlorhexidine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000492	0.00124	CcSEcCtD
Chlorhexidine—Arthralgia—Capecitabine—kidney cancer	0.000488	0.00123	CcSEcCtD
Chlorhexidine—Myalgia—Capecitabine—kidney cancer	0.000488	0.00123	CcSEcCtD
Chlorhexidine—Pain—Paclitaxel—kidney cancer	0.000487	0.00123	CcSEcCtD
Chlorhexidine—SLC47A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000486	0.0116	CbGpPWpGaD
Chlorhexidine—Discomfort—Capecitabine—kidney cancer	0.000482	0.00121	CcSEcCtD
Chlorhexidine—Dry mouth—Capecitabine—kidney cancer	0.000477	0.0012	CcSEcCtD
Chlorhexidine—SLC47A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000469	0.0112	CbGpPWpGaD
Chlorhexidine—SLC47A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000468	0.0111	CbGpPWpGaD
Chlorhexidine—SLC47A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000468	0.0111	CbGpPWpGaD
Chlorhexidine—SLC47A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000468	0.0111	CbGpPWpGaD
Chlorhexidine—Stomatitis—Doxorubicin—kidney cancer	0.00046	0.00116	CcSEcCtD
Chlorhexidine—Urticaria—Paclitaxel—kidney cancer	0.000452	0.00114	CcSEcCtD
Chlorhexidine—Headache—Vincristine—kidney cancer	0.000449	0.00113	CcSEcCtD
Chlorhexidine—Sinusitis—Doxorubicin—kidney cancer	0.000443	0.00112	CcSEcCtD
Chlorhexidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000428	0.0102	CbGpPWpGaD
Chlorhexidine—Headache—Gemcitabine—kidney cancer	0.000426	0.00107	CcSEcCtD
Chlorhexidine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000426	0.00107	CcSEcCtD
Chlorhexidine—Rhinitis—Doxorubicin—kidney cancer	0.000425	0.00107	CcSEcCtD
Chlorhexidine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000422	0.00106	CcSEcCtD
Chlorhexidine—Pharyngitis—Doxorubicin—kidney cancer	0.000421	0.00106	CcSEcCtD
Chlorhexidine—Paraesthesia—Capecitabine—kidney cancer	0.00042	0.00106	CcSEcCtD
Chlorhexidine—Hypersensitivity—Paclitaxel—kidney cancer	0.00042	0.00106	CcSEcCtD
Chlorhexidine—Dyspepsia—Capecitabine—kidney cancer	0.000411	0.00104	CcSEcCtD
Chlorhexidine—Pain—Capecitabine—kidney cancer	0.0004	0.00101	CcSEcCtD
Chlorhexidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000399	0.0095	CbGpPWpGaD
Chlorhexidine—Urticaria—Capecitabine—kidney cancer	0.000371	0.000935	CcSEcCtD
Chlorhexidine—Erythema—Doxorubicin—kidney cancer	0.000369	0.000929	CcSEcCtD
Chlorhexidine—Dysgeusia—Doxorubicin—kidney cancer	0.000361	0.00091	CcSEcCtD
Chlorhexidine—Back pain—Doxorubicin—kidney cancer	0.000357	0.000899	CcSEcCtD
Chlorhexidine—Headache—Paclitaxel—kidney cancer	0.000357	0.000898	CcSEcCtD
Chlorhexidine—Hypersensitivity—Capecitabine—kidney cancer	0.000344	0.000867	CcSEcCtD
Chlorhexidine—Cough—Doxorubicin—kidney cancer	0.000322	0.000811	CcSEcCtD
Chlorhexidine—Hypertension—Doxorubicin—kidney cancer	0.000319	0.000802	CcSEcCtD
Chlorhexidine—Arthralgia—Doxorubicin—kidney cancer	0.000314	0.000791	CcSEcCtD
Chlorhexidine—Myalgia—Doxorubicin—kidney cancer	0.000314	0.000791	CcSEcCtD
Chlorhexidine—SLC47A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000313	0.00745	CbGpPWpGaD
Chlorhexidine—Discomfort—Doxorubicin—kidney cancer	0.00031	0.000782	CcSEcCtD
Chlorhexidine—SLC22A3—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00031	0.00738	CbGpPWpGaD
Chlorhexidine—Dry mouth—Doxorubicin—kidney cancer	0.000307	0.000774	CcSEcCtD
Chlorhexidine—SLC47A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000302	0.0072	CbGpPWpGaD
Chlorhexidine—SLC47A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000302	0.00718	CbGpPWpGaD
Chlorhexidine—SLC47A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000302	0.00718	CbGpPWpGaD
Chlorhexidine—SLC47A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000302	0.00718	CbGpPWpGaD
Chlorhexidine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000301	0.000758	CcSEcCtD
Chlorhexidine—Headache—Capecitabine—kidney cancer	0.000293	0.000737	CcSEcCtD
Chlorhexidine—SLC22A3—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000275	0.00653	CbGpPWpGaD
Chlorhexidine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000274	0.000691	CcSEcCtD
Chlorhexidine—Paraesthesia—Doxorubicin—kidney cancer	0.000271	0.000681	CcSEcCtD
Chlorhexidine—Dyspepsia—Doxorubicin—kidney cancer	0.000265	0.000668	CcSEcCtD
Chlorhexidine—Pain—Doxorubicin—kidney cancer	0.000258	0.000649	CcSEcCtD
Chlorhexidine—SLC47A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000247	0.00588	CbGpPWpGaD
Chlorhexidine—Urticaria—Doxorubicin—kidney cancer	0.000239	0.000603	CcSEcCtD
Chlorhexidine—SLC47A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000238	0.00567	CbGpPWpGaD
Chlorhexidine—Hypersensitivity—Doxorubicin—kidney cancer	0.000222	0.000559	CcSEcCtD
Chlorhexidine—SLC22A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000195	0.00463	CbGpPWpGaD
Chlorhexidine—Headache—Doxorubicin—kidney cancer	0.000189	0.000475	CcSEcCtD
Chlorhexidine—SLC47A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000188	0.00448	CbGpPWpGaD
Chlorhexidine—SLC22A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000181	0.00432	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000172	0.0041	CbGpPWpGaD
Chlorhexidine—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000164	0.00389	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00016	0.00382	CbGpPWpGaD
Chlorhexidine—SLC47A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000159	0.00379	CbGpPWpGaD
Chlorhexidine—SLC22A3—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000158	0.00376	CbGpPWpGaD
Chlorhexidine—SLC22A3—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000158	0.00375	CbGpPWpGaD
Chlorhexidine—SLC22A3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000158	0.00375	CbGpPWpGaD
Chlorhexidine—SLC22A3—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000158	0.00375	CbGpPWpGaD
Chlorhexidine—SLC47A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000154	0.00366	CbGpPWpGaD
Chlorhexidine—SLC22A2—Neuronal System—KCNMA1—kidney cancer	0.000152	0.00363	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000147	0.0035	CbGpPWpGaD
Chlorhexidine—SLC22A1—Neuronal System—KCNMA1—kidney cancer	0.000142	0.00338	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—ACY1—kidney cancer	0.000141	0.00335	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000137	0.00326	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000128	0.00305	CbGpPWpGaD
Chlorhexidine—SLC47A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000121	0.00289	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—PDHB—kidney cancer	0.00012	0.00284	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000119	0.00284	CbGpPWpGaD
Chlorhexidine—SLC22A2—Neuronal System—ACHE—kidney cancer	0.000113	0.00268	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—CCBL1—kidney cancer	0.000112	0.00267	CbGpPWpGaD
Chlorhexidine—SLC47A2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000107	0.00253	CbGpPWpGaD
Chlorhexidine—SLC22A1—Neuronal System—ACHE—kidney cancer	0.000105	0.0025	CbGpPWpGaD
Chlorhexidine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000103	0.00244	CbGpPWpGaD
Chlorhexidine—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	9.91e-05	0.00236	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	9.89e-05	0.00235	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	9.89e-05	0.00235	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	9.89e-05	0.00235	CbGpPWpGaD
Chlorhexidine—SLC22A2—Neuronal System—BCHE—kidney cancer	9.82e-05	0.00234	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—GLIPR1—kidney cancer	9.75e-05	0.00232	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—PPAT—kidney cancer	9.75e-05	0.00232	CbGpPWpGaD
Chlorhexidine—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	9.57e-05	0.00228	CbGpPWpGaD
Chlorhexidine—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	9.24e-05	0.0022	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	9.22e-05	0.00219	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	9.22e-05	0.00219	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	9.22e-05	0.00219	CbGpPWpGaD
Chlorhexidine—SLC22A1—Neuronal System—BCHE—kidney cancer	9.15e-05	0.00218	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—APRT—kidney cancer	9.06e-05	0.00216	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—FH—kidney cancer	9.06e-05	0.00216	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—ACY1—kidney cancer	8.82e-05	0.0021	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—GPC3—kidney cancer	8.52e-05	0.00203	CbGpPWpGaD
Chlorhexidine—SLC22A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.32e-05	0.00198	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—CA2—kidney cancer	8.29e-05	0.00197	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—ACY1—kidney cancer	8.22e-05	0.00196	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—ALAD—kidney cancer	8.08e-05	0.00192	CbGpPWpGaD
Chlorhexidine—SLC22A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.03e-05	0.00191	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—ST3GAL2—kidney cancer	7.88e-05	0.00188	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—ALDH1A1—kidney cancer	7.7e-05	0.00183	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—PDHB—kidney cancer	7.5e-05	0.00178	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—PGK1—kidney cancer	7.39e-05	0.00176	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—SLC5A3—kidney cancer	7.39e-05	0.00176	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—LDHB—kidney cancer	7.24e-05	0.00172	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—CCBL1—kidney cancer	7.05e-05	0.00168	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—PDHB—kidney cancer	6.99e-05	0.00166	CbGpPWpGaD
Chlorhexidine—SLC47A1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.86e-05	0.00163	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—CCBL1—kidney cancer	6.57e-05	0.00156	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmission across Chemical Synapses—BRAF—kidney cancer	6.54e-05	0.00156	CbGpPWpGaD
Chlorhexidine—SLC22A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.34e-05	0.00151	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—CA9—kidney cancer	6.28e-05	0.00149	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—GLIPR1—kidney cancer	6.11e-05	0.00145	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—PPAT—kidney cancer	6.11e-05	0.00145	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmission across Chemical Synapses—BRAF—kidney cancer	6.1e-05	0.00145	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—GLIPR1—kidney cancer	5.7e-05	0.00136	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—PPAT—kidney cancer	5.7e-05	0.00136	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—FH—kidney cancer	5.68e-05	0.00135	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—APRT—kidney cancer	5.68e-05	0.00135	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmission across Chemical Synapses—RAF1—kidney cancer	5.46e-05	0.0013	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—GPC3—kidney cancer	5.34e-05	0.00127	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—CRABP1—kidney cancer	5.34e-05	0.00127	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—APRT—kidney cancer	5.3e-05	0.00126	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—FH—kidney cancer	5.3e-05	0.00126	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.22e-05	0.00124	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—CA2—kidney cancer	5.2e-05	0.00124	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmission across Chemical Synapses—RAF1—kidney cancer	5.09e-05	0.00121	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—ALAD—kidney cancer	5.06e-05	0.00121	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.04e-05	0.0012	CbGpPWpGaD
Chlorhexidine—SLC22A2—Neuronal System—BRAF—kidney cancer	5.01e-05	0.00119	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—GPC3—kidney cancer	4.98e-05	0.00118	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—ITPR2—kidney cancer	4.96e-05	0.00118	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—ST3GAL2—kidney cancer	4.94e-05	0.00118	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.86e-05	0.00116	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—CA2—kidney cancer	4.84e-05	0.00115	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—ALDH1A1—kidney cancer	4.83e-05	0.00115	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—ALAD—kidney cancer	4.72e-05	0.00112	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.7e-05	0.00112	CbGpPWpGaD
Chlorhexidine—SLC22A1—Neuronal System—BRAF—kidney cancer	4.67e-05	0.00111	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—SLC5A3—kidney cancer	4.63e-05	0.0011	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—PGK1—kidney cancer	4.63e-05	0.0011	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—ST3GAL2—kidney cancer	4.61e-05	0.0011	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—LDHB—kidney cancer	4.54e-05	0.00108	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—ACHE—kidney cancer	4.53e-05	0.00108	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—GSTT1—kidney cancer	4.53e-05	0.00108	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—ALDH1A1—kidney cancer	4.5e-05	0.00107	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—PGK1—kidney cancer	4.32e-05	0.00103	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—SLC5A3—kidney cancer	4.32e-05	0.00103	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—SCARB1—kidney cancer	4.29e-05	0.00102	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—PTGS1—kidney cancer	4.24e-05	0.00101	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—LDHB—kidney cancer	4.23e-05	0.00101	CbGpPWpGaD
Chlorhexidine—SLC22A2—Neuronal System—RAF1—kidney cancer	4.19e-05	0.000996	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—PSMD7—kidney cancer	4.16e-05	0.00099	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.98e-05	0.000946	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—BCHE—kidney cancer	3.94e-05	0.000938	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—CA9—kidney cancer	3.94e-05	0.000937	CbGpPWpGaD
Chlorhexidine—SLC22A1—Neuronal System—RAF1—kidney cancer	3.9e-05	0.000928	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—SLC5A5—kidney cancer	3.9e-05	0.000927	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—SLC2A1—kidney cancer	3.76e-05	0.000895	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.75e-05	0.000892	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.71e-05	0.000882	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—CA9—kidney cancer	3.67e-05	0.000874	CbGpPWpGaD
Chlorhexidine—SLC22A3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.59e-05	0.000854	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.49e-05	0.000831	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—CRABP1—kidney cancer	3.35e-05	0.000797	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—GSTP1—kidney cancer	3.14e-05	0.000747	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—CRABP1—kidney cancer	3.12e-05	0.000743	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—ITPR2—kidney cancer	3.11e-05	0.000741	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—ABCB1—kidney cancer	2.97e-05	0.000707	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—ITPR2—kidney cancer	2.9e-05	0.000691	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—GSTM1—kidney cancer	2.88e-05	0.000686	CbGpPWpGaD
Chlorhexidine—SLC22A2—Neuronal System—MAPK1—kidney cancer	2.87e-05	0.000683	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—GSTT1—kidney cancer	2.84e-05	0.000676	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—ACHE—kidney cancer	2.84e-05	0.000676	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—CYP1A1—kidney cancer	2.73e-05	0.00065	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—SCARB1—kidney cancer	2.69e-05	0.00064	CbGpPWpGaD
Chlorhexidine—SLC22A1—Neuronal System—MAPK1—kidney cancer	2.68e-05	0.000637	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—PTGS1—kidney cancer	2.66e-05	0.000633	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—GSTT1—kidney cancer	2.65e-05	0.00063	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—ACHE—kidney cancer	2.65e-05	0.00063	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—PSMD7—kidney cancer	2.61e-05	0.000621	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—SCARB1—kidney cancer	2.5e-05	0.000596	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—PTGS1—kidney cancer	2.48e-05	0.00059	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—BCHE—kidney cancer	2.47e-05	0.000589	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—SLC5A5—kidney cancer	2.44e-05	0.000581	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—PSMD7—kidney cancer	2.43e-05	0.000579	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—SLC2A1—kidney cancer	2.36e-05	0.000561	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—BCHE—kidney cancer	2.31e-05	0.000549	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—SLC5A5—kidney cancer	2.28e-05	0.000542	CbGpPWpGaD
Chlorhexidine—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.25e-05	0.000535	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—SLC2A1—kidney cancer	2.2e-05	0.000523	CbGpPWpGaD
Chlorhexidine—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.1e-05	0.000499	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—POMC—kidney cancer	2.04e-05	0.000485	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—GSTP1—kidney cancer	1.97e-05	0.000468	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—ABCB1—kidney cancer	1.86e-05	0.000443	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—GSTP1—kidney cancer	1.83e-05	0.000436	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—GSTM1—kidney cancer	1.81e-05	0.00043	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—ABCB1—kidney cancer	1.74e-05	0.000413	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—CYP1A1—kidney cancer	1.71e-05	0.000408	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—GSTM1—kidney cancer	1.69e-05	0.000401	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—PTGS2—kidney cancer	1.63e-05	0.000387	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—CYP1A1—kidney cancer	1.6e-05	0.00038	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—PTEN—kidney cancer	1.42e-05	0.000337	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—POMC—kidney cancer	1.28e-05	0.000304	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—POMC—kidney cancer	1.19e-05	0.000284	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—PTGS2—kidney cancer	1.02e-05	0.000243	CbGpPWpGaD
Chlorhexidine—SLC22A3—Metabolism—PIK3CA—kidney cancer	1e-05	0.000238	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—PTGS2—kidney cancer	9.5e-06	0.000226	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—PTEN—kidney cancer	8.89e-06	0.000212	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—PTEN—kidney cancer	8.29e-06	0.000197	CbGpPWpGaD
Chlorhexidine—SLC22A2—Metabolism—PIK3CA—kidney cancer	6.27e-06	0.000149	CbGpPWpGaD
Chlorhexidine—SLC22A1—Metabolism—PIK3CA—kidney cancer	5.85e-06	0.000139	CbGpPWpGaD
